New Hope: WHO To Consider Covaxin Approval On Oct 26
New York: There’s a new date for Covaxin’s likely approval by World Health Organization (WHO).
According to WHO Chief Scientist Soumya Swaminathan, the global health body’s technical advisory group will meet on October 26 to consider emergency use listing (EUL) for the Bharat Biotech-developed COVID-19 vaccine.
“@WHO has been working closely with @BharatBiotech to complete the dossier. Our goal is to have a broad portfolio of vaccines approved for emergency use & to expand access to populations everywhere,” Swaminathan tweeted on Sunday.
The technical advisory group will meet on Oct 26th to consider EUL for #Covaxin. @WHO has been working closely with @BharatBiotech to complete the dossier. Our goal is to have a broad portfolio of vaccines approved for emergency use & to expand access to populations everywhere https://t.co/lqQIyqItF9
— Soumya Swaminathan (@doctorsoumya) October 17, 2021
Bharat Biotech, which developed India’s first indigenous vaccine against coronavirus, has been submitting data to WHO on a rolling basis. Additional informational was submitted at WHO’s request on September 27 also. However, the UN body has kept delaying approval.
Covaxin, which along with Covishield was used at the start of India’s mass vaccination programme in January, has been recently approved by Indian drug regulator for emergency use among 2 to 18 years old.